Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)
China · Delayed Price · Currency is CNY 9.65
+0.15 (1.58%)
Apr 10, 2026, 12:19 PM CST
SHE:300534 Revenue
In the year 2025, Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD had annual revenue of 886.96M CNY, down -14.64%. Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD had revenue of 239.67M in the quarter ending December 31, 2025, a decrease of -11.49%.
Revenue
886.96M
Revenue Growth
-14.92%
P/S Ratio
3.25
Revenue / Employee
1.40M
Employees
634
Market Cap
2.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 886.96M | -152.11M | -14.64% |
| Dec 31, 2024 | 1.04B | -40.98M | -3.79% |
| Dec 31, 2023 | 1.08B | 280.37M | 35.06% |
| Jan 1, 2023 | 799.68M | 511.87M | 177.85% |
| Jan 1, 2022 | 287.81M | 32.91M | 12.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Fengyuan Pharmaceutical | 4.15B |
| Enwei Pharmaceutical | 888.64M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Zhejiang Shengda Bio-Pharm | 839.82M |
| Baotou Dongbao Bio-Tech Co.,Ltd | 745.31M |
| Ginwa Enterprise (Group) | 550.44M |
| Chengdu huasun technology group Inc. , LTD. | 545.50M |
| Shaanxi Kanghui Pharmaceutical | 513.23M |